News - The Yozma Group

Main
News

News

All 67

Press Release 24

In the News 43

Event

22 Posts

Press Release

UltraSight to Expand Access to Echocardiographic Monitoring for Obstructive Hypertrophic Cardiomyopathy Patients

Feb 21 2025
Press Release

Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease

Feb 21 2025
Press Release

Maverick SDK 2.6.0, available as of November 25, 2024!

Feb 07 2025
Press Release

Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor

Feb 07 2025
Press Release

Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication

Feb 07 2025
Press Release

Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme

Oct 21 2024
Press Release

Alpha Tau Treats First Patient with Recurrent Lung Cancer

Oct 10 2024
Press Release

Ultra-Red has expanded its operations in Japan through a new partnership with GSX

Sep 24 2024
Press Release

FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC

Sep 20 2024
Press Release

StoreDot welcomes top auto industry analyst Rod Lache to its advisory board, further expanding globally

Sep 18 2024
Press Release

StoreDot Accelerates EV adoption: 10-Minute Charging of Large Prismatic Batteries Now a Reality

Sep 10 2024
Press Release

Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium

Aug 21 2024

1
2